Pharma looks for quantum leap in drug development

By Alison Snyder, Axios

Quantum computing and biotech companies are testing whether next-generation computing technology could help them develop better drugs and cut the time and cost of finding new ones.

Why it matters: Quantum computing is advancing, but it still hasn’t been harnessed to solve real-world problems that classical computers can’t. Biotech could be a proving ground for the practicality of quantum computing, which some skeptics say has been hyped, like AI.